{{Rsnum
|rsid=2055109
|Chromosome=3
|position=87418182
|Orientation=minus
|GMAF=0.1515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.9 | 35.4 | 2.7
| HCB | 87.6 | 11.7 | 0.7
| JPT | 82.3 | 17.7 | 0.0
| YRI | 78.2 | 21.8 | 0.0
| ASW | 87.7 | 10.5 | 1.8
| CHB | 87.6 | 11.7 | 0.7
| CHD | 87.2 | 12.8 | 0.0
| GIH | 61.4 | 32.7 | 5.9
| LWK | 71.8 | 24.5 | 3.6
| MEX | 72.4 | 25.9 | 1.7
| MKK | 67.9 | 30.8 | 1.3
| TSI | 47.1 | 41.2 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22366784
|Title=Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}